As per the analysts at Zion Market Research, the overall capital of the — global sirolimus market has reached around US$ 282.06 million in 2019 and is anticipated to attain US$ 307.33 million by 2026, growing at about 1.1% CAGR during the forecast period. The existence of a huge count of market players had made it extremely fragmented. The leading participants active in the global sirolimus market consist of Biocon, Pfizer, Inc., Concept Medical, Inc., Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Stentys SA, Intas Pharmaceuticals Ltd., and Zydus Cadila. The rise in the trend of product launches & approvals and mergers & acquisitions in emerging economies is anticipated to drive the growth of the global sirolimus market.
Rising Count Of Lifestyle-Associated Disorders To Surge The Demand For Sirolimus
The global sirolimus market growth can be credited to factors such as the rise in prevalence of target diseases, increase in the count of lifestyle-associated disorders, rise in healthcare expenditure, development in healthcare infrastructure, and promising pipeline. In addition, a rise in inclination toward generic drug versions and related side-effects are anticipated to hamper the sirolimus market growth during the forecast period. To cite, in November 2019, as per data represented at VIVA 19 from the SELUTION study, a sirolimus-coated balloon used for treating peripheral artery disease was related to positive results at 2 years. In the first-in-human study, 50 participants were treated with the Selution SLR, MedAlliance and the rate of primary patency at 2 years was found to be 94.4% in the per-protocol population and 81.7% in the intention-to-treat population.
Get Free Sample Report PDF @ https://www.zionmarketresearch.com/sample/sirolimus-market
Increased Adoption Of Technologies Is Likely To Help North America Dominate The Market
The global sirolimus market is bifurcated based on distribution channel, applications, and region. Based on the distribution channel, the market is divided into retail pharmacies, online pharmacies, and hospital pharmacies. Based on the application, the global sirolimus market is divided into lymphangioleiomyomatosis, organ transplant rejection, catheter devices, and sirolimus-coated balloons. The organ transplant rejection segment is projected to rule all over the other market segments owing to the rising number of organ transplants and the enhancing healthcare services in a number of regions around the world. Regionally, the global sirolimus market is grouped into Asia Pacific, Latin America, the Middle East & Africa, Europe, and North America. Among these regions, in 2018, the maximum stake of the global sirolimus market was held by North America and is anticipated to dominate the market during the forecast period as well. The market growth in this region is propelled by the high adoption rate of technologies and the existence of key players. Moreover, an increase in the count of organ transplants is anticipated to drive the sirolimus market in North America.
The global sirolimus market is segmented as follows:
Organ Transplant Rejection
Sirolimus Coated Balloons & Catheter Devices
By Distribution Channel
Rest of Europe
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Browse TOC of this Report @ https://www.zionmarketresearch.com/toc/sirolimus-market
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Release ID: 88984121